- Motley Fool•31 minutes ago3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity
This stock is back in the game with a pipeline full of near-term catalysts, superstar oncology drugs, and a 3.5% dividend yield.
Die perfekte Welle - 3 Surfer und 33 Millionen
Drei Surfer ziehen aus, um den Jackpot zu knacken. Nun sind sie um 33 Millionen Euro reicher und wissen ziemlich genau, wo ihre nächste Reise hingeht.
- Investor's Business Daily•6 hours agoEli Lilly Looks To Corral More Animal-Health Business Vs. Zoetis
Eli Lilly will boost its animal vaccines business vs. Zoetis by acquiring a unit of drugmaker Boehringer.
Pfizer Inc. (PFE)
Add to watchlist
NYSE - NYSE Real Time Price. Currency in USD
| Open | 33.73 |
| Prev Close | 33.72 |
| Bid | 33.88 x 900 |
| Ask | 33.96 x 600 |
| Day's Range | 33.67 - 33.98 |
| 52wk Range | 28.25 - 37.39 |
| 1y Target Est | N/A |
| Market Cap | 205.63B |
| P/E Ratio (ttm) | 30.05 |
| Beta | 0.98 |
| Volume | 13,603,491 |
| Avg Vol (3m) | 19,201,818 |
| Dividend & Yield | 1.20 (3.54%) |
| Earnings Date | N/A |
